One-day systemic corticosteroid administration for asthma and future “short bursts” risk in real clinical practice

References

• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2019. Available from: www.ginasthma.org. [accessed 2020 March 24].
   Google Scholar
• Castillo JR, Peters SP, Busse WW. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment. J Allergy Clin Immunol Pract. 2017;5(4):918–927. doi:10.1016/j.jaip.2017.05.001.
   PubMed Web of Science ®Google Scholar
• The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European network for understanding mechanisms of severe asthma. Eur Respir J. 2003;22:470–477. doi:10.1183/09031936.03.00261903.
   PubMed Web of Science ®Google Scholar
• Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization of the severe asthma phenotype by the national heart, lung, and blood institute’s severe asthma research program. J Allergy Clin Immunol. 2007;119(2):405–413. doi:10.1016/j.jaci.2006.11.639.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–116.e7. doi:10.1016/j.jaci.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Sweeney J, Patterson CC, Menzies-Gow A, Niven RM, Mansur AH, Bucknall C, Chaudhuri R, Price D, Brightling CE, Heaney LG, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the optimum patient care research database and the British thoracic difficult asthma registry. Thorax. 2016;71(4):339–346. doi:10.1136/thoraxjnl-2015-207630.
   PubMed Web of Science ®Google Scholar
• Waljee AK, Rogers MAM, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ, Nallamothu BK. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi:10.1136/bmj.j1415.
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang D, Hua D, Liao H, Chen R. Short-term oral corticosteroids for initial treatment of moderate-to-severe persistent asthma: A double-blind, randomized, placebo-controlled trial. Respir Med. 2020;172:106126. doi:10.1016/j.rmed.2020.106126.
   PubMed Web of Science ®Google Scholar
• Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo CA.Jr. Asthma exacerbations in North American adults: who are the "frequent fliers" in the emergency department? Chest. 2005;127(5):1579–1586. doi:10.1378/chest.127.5.1579.
   PubMed Web of Science ®Google Scholar
• Koga T, Oshita Y, Kamimura T, Koga H, Aizawa H. Characterisation of patients with frequent exacerbation of asthma. Respir Med. 2006;100(2):273–278. doi:10.1016/j.rmed.2005.05.017.
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125(6):1178–1187. doi:10.1016/j.jaci.2010.04.021.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, Nizankowska-Mogilnicka E, Gjomarkaj M, Gaga M, Brusselle G, et al. Frequent exacerbators–a distinct phenotype of severe asthma. Clin Exp Allergy. 2014;44(2):212–221. doi:10.1111/cea.12179.
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Bacharier LB. Inhaled corticosteroids for the prevention of asthma exacerbations. Ann Allergy Asthma Immunol. 2021;127(5):524–529. doi:10.1016/j.anai.2021.08.014.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, Ichinose M, Iwanaga T, Kondo R, Nagata M, et al. Japanese guidelines for adult asthma 2020. Allergol Int. 2020;69(4):519–548. doi:10.1016/j.alit.2020.08.001.
   PubMed Web of Science ®Google Scholar
• Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med. 2017;195(3):302–313. doi:10.1164/rccm.201602-0419OC.
   PubMed Web of Science ®Google Scholar
• Peters MC, Mauger D, Ross KR, Phillips B, Gaston B, Cardet JC, Israel E, Levy BD, Phipatanakul W, Jarjour NN, et al. Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency. Am J Respir Crit Care Med. 2020;202(7):973–982. doi:10.1164/rccm.201909-1813OC.
   PubMed Web of Science ®Google Scholar
• Bloom CI, Palmer T, Feary J, Quint JK, Cullinan P. Exacerbation patterns in adults with asthma in England. A population-based study. Am J Respir Crit Care Med. 2019;199(4):446–453. doi:10.1164/rccm.201808-1516OC.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Uno T, Sato H, Jinno M, Hirai K, Miyata Y, Yamaguchi M, Ohta S, Homma T, Yamamoto M, et al. Predicting future risk of exacerbations in Japanese patients with adult asthma: a prospective 1-year follow up study. Allergol Int. 2017;66(4):568–573. doi:10.1016/j.alit.2017.02.013.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. doi:10.1164/rccm.200801-060ST.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kusakabe Y, Yamamoto N, Tashima M, Tashima N, Ito C, Aihara K, Yamaoka S, Mishima M. Characteristics of patients with frequent systemic corticosteroid bursts for asthma in real clinical practice: are there frequent "short bursts?”. J Asthma. 2022;59(6):1095–1102. doi:10.1080/02770903.2021.1908350.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013.
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Gossage D, Tran TN. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract. 2014;2(6):741–750. doi:10.1016/j.jaip.2014.06.005.
   PubMed Web of Science ®Google Scholar
• Zhang Y, He J, Yuan Y, Faramand A, Fang F, Ji H. Increased versus stable dose of inhaled corticosteroids for asthma exacerbations: A systematic review and meta-analysis. Clin Exp Allergy. 2019;49(10):1283–1290. doi:10.1111/cea.13450.
   PubMed Web of Science ®Google Scholar
• Kerstjens HAM, Maspero J, Chapman KR, van Zyl-Smit RN, Hosoe M, Tanase A-M, Lavecchia C, Pethe A, Shu X, D'Andrea P, et al. Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study. Lancet Respir Med. 2020;8(10):1000–1012. doi:10.1016/s2213-2600(20)30190-9.
   PubMed Web of Science ®Google Scholar
• Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(6):1469–1485. doi:10.1016/j.cell.2021.02.016.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. doi:10.1164/rccm.200711-1754OC.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R, Castro M, Curran-Everett D, Fitzpatrick AM, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–323. doi:10.1164/rccm.200906-0896OC.
   PubMed Web of Science ®Google Scholar
• Huang H-L, Huang Y-J, Chu Y-C, Chen C-W, Yang H-C, Hwang J-S, Chen C-H, Chan T-C. Exploring factors underlying poorly-controlled asthma in adults by integrating phenotypes and genotypes associated with obesity and asthma: a case-control study. J Asthma Allergy. 2023;16:135–147. doi:10.2147/jaa.s397067.
   PubMed Web of Science ®Google Scholar
• Dixon AE, Pratley RE, Forgione PM, Kaminsky DA, Whittaker-Leclair LA, Griffes LA, Garudathri J, Raymond D, Poynter ME, Bunn JY, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128(3):508–515.e1-2. doi:10.1016/j.jaci.2011.06.009.
   PubMed Web of Science ®Google Scholar
• Ma J, Strub P, Xiao L, Lavori PW, Camargo CA, Wilson SR, Gardner CD, Buist AS, Haskell WL, Lv N, et al. Behavioral weight loss and physical activity intervention in obese adults with asthma. A randomized trial. Ann Am Thorac Soc. 2015;12(1):1–11. doi:10.1513/AnnalsATS.201406-271OC.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Ritondo BL, Calzetta L. Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies. Eur Respir J. 2021;58(3):2004233. doi:10.1183/13993003.04233-2020.
   PubMed Web of Science ®Google Scholar
• Vinnikov D, Raushanova A, Mukatova I, Nurpeissov T, Кushekbayeva A, Toxarina A, Yessimova B, Bespayeva F, Brimkulov N. Asthma control in Kazakhstan: need for urgent action. BMC Pulm Med. 2023;23(1):7. doi:10.1186/s12890-022-02287-2.
   PubMed Web of Science ®Google Scholar
• Jindal SK, Aggarwal AN, Gupta D. Diurnal variability of peak expiratory flow. J Asthma. 2002;39(5):363–373. doi:10.1081/jas-120004029.
   PubMed Web of Science ®Google Scholar